$IVST Innovest Global Appoints New Finance Leader and Sets

New Post Public Reply Private Reply Replies (0) Message Board
marketreturn
711
$IVST
Innovest Global Appoints New Finance Leader and Sets Investor Conference Schedule to Take Company Through Next Phase of Growth
BusinessWire - Mon Aug 12, 8:15AM CDT
Innovest Global Inc. (OTC Markets: IVST), a diversified industrials company, announced the appointment of Indrani Egleston as the Executive Vice President of Finance and Controls effective immediately. Ms. Egleston brings strong financial and professional public company experience to Innovest Global. She has held various strategic leadership financial roles including Internal Audit, Controlling, Financial Planning and Analysis and Mergers and Acquisitions throughout her tenured career at Covia Holdings Corp. (NYSE:CVIA, formerly Fairmount Santrol NYSE:FMSA), Nordson Corporation (Nasdaq:NDSN), and PWC LLP. Ms. Egleston holds an Executive MBA from Case Western Reserve University and a BBA from the University of Michigan and will oversee our finance, accounting, internal control, and investor relations functions.

The Company's CFO, Mike Yukich, will continue to provide operational and tactical execution, and was instrumental in defining the requirements which led to the appointment of Ms. Egleston.

Dan Martin, Chairman and CEO, stated, "Indrani's appointment to our Executive team is an important milestone, adding extensive public company finance, internal controls and strategic planning capabilities to our world-class team. I am confident in Indrani's abilities to elevate our company, pioneer financial and capital planning, and identify opportunities where we can deliver greater value for all of our stakeholders."

With the addition of Ms. Egleston to the Innovest Global Executive team, the Company is establishing plans to finalize the uplist requirements designed to position the Company to leave the 'pink sheets' this fall. The Company will also be attending key institutional investor conferences this fall targeting industrial focused investors attracted to Innovest Global's rapid growth and unique value proposition.

The investor conferences feature presentations to potential institutional partners followed by one-on-one meetings. The targeted conferences includes a New York City event and Toronto event in the third and fourth quarter 2019 with a focus towards mid-cap investment institutions within North America and Asian investors who have an expressed interest in industrial business lines.

Mr. Martin continued, "We thank our supportive and patient shareholders for giving us the ability to focus on growing a meaningful business which includes establishing a strong executive team. By prioritizing business growth first, we're confident the approach to an institutional audience will be even more successful at generating interest in our company. Investor conferences coupled with continued strong revenues and compliance upgrades, are a path we feel will well-position the Company for executing its 2020 plans."

This news follows last week's announcement of second quarter 2019 financial results for the quarter ended June 30, 2019. Second quarter 2019 net sales were $17.3 million; an increase of $16.2 million from $1.1 million in the second quarter 2018, and $4.4 million or 34% higher compared with $12.9 million in the first quarter 2019. Year to date through June 30, 2019, net sales were $30.2 million, over 20% ahead of year to date 2019 guidance (click here for guidance).

About Innovest Global, Inc.

Innovest Global, Inc. (OTC Markets: IVST) has operations in industrials (commercial and industrial products and services, energy, and building materials) and investments in biotechnology. Our primary growth strategy is to acquire existing companies in a select few industries and attract new customers in cost effective ways. For more information follow on social media @innovestglobal or visit http://innovestglobal.com.

Innovest Global, Inc. (IVST) Stock Research Links

IVST Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

TSA PreCheck Study Reveals Time Savings and Travel Insights

Updated Category News Views 379

Understanding TSA PreCheck's Impact on Travelers The latest survey reveals some interesting insights about TSA PreCheck, especially concerning the time savings that members experience at security checkpoints. Conducted by Upgraded Points, this enlightening study assessed the experience of over 1,500 travelers to evaluate the true advantages of holding a TSA PreCheck...

Continue Reading
Intermap Technologies Enhances Geospatial Solutions with New Offering

Updated Category News Views 217

Intermap Technologies Announces New Prospectus Supplement DENVER – Intermap Technologies Corporation (TSX: IMP; OTCQB: ITMSF), a recognized leader in 3D geospatial products and intelligence solutions, has filed a prospectus supplement in the context of a strategically planned public offering. This initiative signifies a promising step forward, with the company aiming to...

Continue Reading
Urgent Investor Notice: Humacyte Legal Claims Investigation

Updated Category News Views 94

Critical Deadline for Humacyte Investors Approaches As time runs short, investors in Humacyte, Inc. (NASDAQ: HUMA) should pay attention. Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively investigating claims on behalf of investors who have suffered losses exceeding $75,000 due to potential violations in federal securities laws. Understanding Your...

Continue Reading
Empowering Women in Banking: Natalie Bartholomew at Alkami Co:lab

Updated Category News Views 226

Empowering Women in Banking: Natalie Bartholomew at Alkami Co:lab Natalie Bartholomew, a highly recognized advocate for women in financial services, will be the featured speaker for the Women in Banking session at Alkami Co:lab 2026. Her expertise and passion are expected to inspire attendees and foster discussions around women's roles in the financial sector. Alkami...

Continue Reading
Investors Anticipate Strong Earnings from OPAL Fuels Soon

Updated Category News Views 161

OPAL Fuels Earnings Report Insights OPAL Fuels OPAL is preparing to release its quarterly earnings report soon, and investors are keenly interested in the results. As the anticipated date for this report approaches, it is essential for investors to stay informed and understand what the expectations are. Projected Earnings Overview Analysts project that OPAL Fuels will...

Continue Reading